Johnson & Johnson: all 3,718 studies

Page 24 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Pharmacokinetics, Tolerability, and Safety of ACT-128800 in Japanese and Caucasian Healthy Male and Female SubjectsCompletedNCT02223832Phase 1
• Study to Assess Adhesion Quality and Wear of Placebo JNJ-35685-AAA-G-023 Transdermal System in Healthy AdultsCompletedNCT02221726Early Phase 1
• Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted ParticipantsCompletedNCT02221180Phase 1
• Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted ParticipantsCompletedNCT02220218Phase 1
• A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected AdultsCompletedNCT02218125Phase 1
• Pharmacokinetic Study of JNJ-42756493 in Healthy ParticipantsCompletedNCT02218073Phase 1
• Prospective Metabolic Surgery in T2DM Chinese SubjectsCompletedNCT02217943Not applicable
• A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 SubstratesCompletedNCT02211079Phase 1
• Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μgCompletedNCT02206295Phase 1
• Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female SubjectsCompletedNCT02206204Phase 1
• Facet Wedge Post Market StudyCompletedNCT02203448
• A Study of ALS-008176 in Infants Hospitalized With RSVCompletedNCT02202356Phase 1
• A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male ParticipantsCompletedNCT02197884Phase 1
• A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 TrialsCompletedNCT02187107Phase 2
• A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male ParticipantsCompletedNCT02180269Phase 1
• A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279CompletedNCT02169973Phase 1
• Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell LymphomaCompletedNCT02169180Phase 2
• An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver TransplantCompletedNCT02165189Phase 2
• A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate CancerCompletedNCT02162836Phase 1
• Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male ParticipantsCompletedNCT02160756Phase 1
• A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial FormulationsCompletedNCT02156375Phase 1
• An Exploratory Genetic Study in Participants With PsoriasisCompletedNCT02155192
• Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal EsketamineCompletedNCT02154334Phase 1
• A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy ParticiantsCompletedNCT02152332Phase 1
• Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy AdultsCompletedNCT02148328Phase 1
• A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPDCompletedNCT02140346Phase 1
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 DaysCompletedNCT02140320Phase 1
• CARES Lumbar Artificial Disc RegistryTerminatedNCT02139527
• A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal CancerCompletedNCT02138422Phase 3
• Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female SubjectsCompletedNCT02136888Phase 1
• A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory InfectionsCompletedNCT02133092
• A Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract InfectionsCompletedNCT02132923
• A Pharmacokinetic, Safety and Tolerability Study of Esketamine in Healthy Elderly and Adult ParticipantsCompletedNCT02129088Phase 1
• A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different FacilitiesCompletedNCT02127593Phase 1
• Mass Balance, Pharmacokinetics, and Metabolism of 14C-labeled ACT-128800 Administered to Healthy Male SubjectsCompletedNCT02126956Phase 1
• OPsumit USers RegistryCompletedNCT02126943
• A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT02123758Phase 1
• A Crossover Study to Evaluate Relative Bioavailability of Two JNJ-54781532 Tablet Formulations in Healthy Adult ParticipantsCompletedNCT02117505Phase 1
• A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT02116569Phase 1
• Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort StudyCompletedNCT02114372
• Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B PatientsCompletedNCT02112799Phase 1
• Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAHCompletedNCT02112487Phase 3
• Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-ManCompletedNCT02110004Phase 1
• A Study of Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy ParticipantsCompletedNCT02103985Phase 1
• A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With SimeprevirCompletedNCT02103699
• Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip ReplacementCompletedNCT02096198
• A Study to Evaluate the Effect of Intranasal Esketamine on Cognitive Functioning in Healthy SubjectsCompletedNCT02094378Phase 1
• A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge ModelCompletedNCT02094365Phase 2
• Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric ParticipantsCompletedNCT02087579Phase 1
• A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCompletedNCT02081495Phase 1
• Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male ParticipantsCompletedNCT02079545Phase 1
• Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With DementiaCompletedNCT02078310Phase 1/2
• A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed ParticipantsCompletedNCT02077803Phase 1
• A Study to Assess the Safety and Pharmacokinetics of a Single Intravenous Administration of CNTO 328 Derived From 2 Different Cell Lines in Healthy ParticipantsCompletedNCT02074800Phase 1
• A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual ComponentsCompletedNCT02073227Phase 1
• A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed ParticipantsCompletedNCT02071368Phase 1
• A Study to Examine the Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of TMC435 in Healthy Chinese ParticipantsCompletedNCT02071355Phase 1
• Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male SubjectsCompletedNCT02068235Phase 1
• A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With AntidepressantsCompletedNCT02067299Phase 1
• A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual ComponentsCompletedNCT02065752Phase 1
• A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of JNJ-42165279 in Healthy Male ParticipantsCompletedNCT02065739Phase 1
• A Clinical Trial to Test the Effect of Experimental Mouth Rinse on Gum DiseaseCompletedNCT02065414Phase 4
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TMC647055 in Combination With Ritonavir (Part 1) and the Co-administration of TMC435, TMC647055 and Ritonavir (Part 2) in Healthy Japanese ParticipantsCompletedNCT02064842Phase 1
• A Study to Evaluate the Pharmacokinetics of Intranasal Esketamine Administered With and Without a Nasal Guide on the Intranasal DeviceCompletedNCT02060929Phase 1
• Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile InfectionCompletedNCT02053181Phase 1
• A Study to Assess the Effect of Food on the Bioavailability of Mebendazole From a Fast-Disintegrating Chewable Formulation of Mebendazole in Healthy ParticipantsCompletedNCT02051738Phase 1
• Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female SubjectsCompletedNCT02050802Phase 1
• A Study to Evaluate of the Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 in Healthy Male ParticipantsCompletedNCT02049697Phase 1
• ENSEAL® G2 Articulating Tissue Sealer in Laparoscopic ColectomyCompletedNCT02044770
• Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With FoodCompletedNCT02039258Phase 1
• Multiple Dose Pharmacokinetics of Canagliflozin/Metformin 150/1,000 mg Fixed Dose CombinationCompletedNCT02039245Phase 1
• A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy VolunteersCompletedNCT02034344
• A Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 in Healthy Male ParticipantsCompletedNCT02031666Phase 1
• Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy SubjectsCompletedNCT02029482Phase 1
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39393406 in Healthy ParticipantsCompletedNCT02023255Phase 1
• A Study to Assess Bioequivalence of a New Tapentadol Extended-Release Tablet With Respect to a Tapentadol Extended Release Tablet Under Fasted Conditions in Healthy SubjectsCompletedNCT02019485Phase 1
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.CompletedNCT02018536Phase 1
• A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR6261 in Japanese Healthy ParticipantsWithdrawnNCT02016066Phase 1
• A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR8020 in Japanese Healthy ParticipantsWithdrawnNCT02015533Phase 1
• Bioequivalence Test for Risperdal 2mg of Janssen KoreaCompletedNCT02012049Phase 1
• Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)CompletedNCT02009488Phase 1
• A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian ParticipantsCompletedNCT02008279Phase 1
• A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic FunctionCompletedNCT02001571Phase 1
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes MellitusCompletedNCT02000700Phase 1
• A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple MyelomaCompletedNCT01998971Phase 1
• A Study to Evaluate the Safety and Efficacy of Ultiva (Remifentanil Hydrochloride) in Pediatric Participants General AnesthetisedCompletedNCT01998165Phase 3
• Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza InfectionWithdrawnNCT01992276Phase 2
• A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT01988961Phase 2
• A Study of Solid Formulations of JNJ-39393406 in Healthy Male ParticipantsCompletedNCT01986491Phase 1
• Registry of the Magellan Robotic SystemTerminatedNCT01984437
• A Study to Assess Bioequivalence of a New Tapentadol Extended-Release 250-mg Tablet With Respect to a Tapentadol Extended-Release 250-mg Tablet in Healthy ParticipantsCompletedNCT01981278Phase 1
• A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian VolunteersCompletedNCT01980303Phase 1
• Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis CCompletedNCT01980290
• A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's DiseaseCompletedNCT01978548Phase 1
• Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD PatientsCompletedNCT01970618Phase 1
• A Study to Investigate the Absorption, Metabolism, and Excretion of JNJ-38518168 After a Single Oral Dose in Healthy Male Participants.CompletedNCT01970020Phase 1
• A Pharmacokinetic Study in Healthy Participants to Assess the Pharmacokinetics and Safety of a Supratherapeutic Dose of PCI-32765 (Ibrutinib) Capsule and Solution Formulations Administered With FoodCompletedNCT01969266Phase 1
• A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer PainCompletedNCT01968018Phase 4
• A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01966549Phase 2
• A Phase II Open Label Study of Xilonix in Subjects With Pyoderma GangrenosumCompletedNCT01965613Phase 2

← Johnson & Johnson overview and focus areas